Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT02923349 |
| Title | A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid Tumors |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Incyte Europe Sàrl |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | GBR | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Rutgers, The State University of New Jersey | New Brunswick | New Jersey | 08901 | United States | Details | |
| New York University Clinical Cancer Center | New York | New York | 10016 | United States | Details | |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| Vall d'Hebron Institute of Oncology (VHIO) | Barcelona | 08035 | Spain | Details | ||
| University Hospital of Laussane (CHUV) | Lausanne | 1011 | Switzerland | Details | ||
| University College Hospital | London | NW1 2PG | United Kingdom | Details | ||
| University of Oxford | Oxford | OX3 7LE | United Kingdom | Details |